Free Trial
LON:IQAI

IQ-AI 4/25/2025 Earnings Report

IQ-AI logo
GBX 0.80 0.00 (0.00%)
As of 05/27/2025 08:18 AM Eastern

IQ-AI EPS Results

Actual EPS
-GBX 0.15
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IQ-AI Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IQ-AI Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

IQ-AI Earnings Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
IQ-AI reports early success in glioblastoma study
See More IQ-AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IQ-AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IQ-AI and other key companies, straight to your email.

About IQ-AI

IQ-AI (LON:IQAI), through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company was incorporated in 1965 and is based in Saint Helier, Jersey.

View IQ-AI Profile

More Earnings Resources from MarketBeat